Skip to main content

MoneyWorks4Me

Lupin informs about press release

10 Dec 2018 Evaluate

Lupin has informed about submission of a Press Release as regards receipt of 'Establishment Inspection Report' from the USFDA, at the company's Pithampur (Unit 3) (Indore) facility. This is a disclosure pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1778.25
Dr. Reddys Labs. 1350.20
Cipla 1380.00
Lupin 2009.00
Zydus Lifesciences 1244.00
View more..